• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[体重低于1000克早产儿严重呼吸窘迫综合征中的表面活性剂替代治疗]

[Surfactant substitution in severe respiratory distress syndrome in premature infants weighing less than 1,000 g].

作者信息

Speer C P, Harms K, Herting E, Müller F, Schröter W, Teichmann A T, Neumann N, Curstedt T, Robertson B

机构信息

Universitäts-Kinderklinik Göttingen.

出版信息

Geburtshilfe Frauenheilkd. 1990 May;50(5):359-64. doi: 10.1055/s-2008-1026261.

DOI:10.1055/s-2008-1026261
PMID:2197165
Abstract

19 preterm infants with severe respiratory distress syndrome (RDS) were treated with a single dose of natural porcine surfactant (Curosurf, 200 mg/kg). 9 patients had a birth weight of less than 1000 g (845 +/- 112 g, mean +/- SD and the mean gestational age was 27.2 +/- 2.1 weeks). The other 10 had a birth weight of greater than 1000 g (1521 +/- 218 g and a mean gestational age 31 +/- 2.8 weeks). Age at treatment was 3 h in infants less than 1000 g and 4 h in patients greater than 1000 g. Both groups of infants showed a rapid improvement in oxygenation and gas exchange within minutes after surfactant replacement. Exposition to greater than 60% and greater than 40% oxygen was identical in both groups. However, time in greater than 21% oxygen was significantly longer in infants less than 1000 g (median 30 days, 8.5 days in patients greater than 1000 g, p less than 0.01). The duration of mechanical ventilation was 33 days, in patients greater than 1000 g and 5 days; p less than 0.01. None of the infants developed a pneumothorax, but 6 out of 9 patients less than 1000 g developed mild bronchopulmonary dysplasia. 2 infants less than 1000 g died at day 5 and day 11 from cardio-circulatory arrest following ligation of a patent ductus arteriosus, and nosocomial septicaemia, respectively. Prolonged mechanical ventilation and exposure to oxygen in patients less than 1000 g cannot be attributed to surfactant deficiency alone.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

19名患有严重呼吸窘迫综合征(RDS)的早产儿接受了单剂量天然猪肺表面活性物质(固尔苏,200mg/kg)治疗。9名患者出生体重低于1000g(845±112g,均值±标准差,平均胎龄为27.2±2.1周)。另外10名出生体重高于1000g(1521±218g,平均胎龄31±2.8周)。出生体重低于1000g的婴儿治疗时年龄为3小时,高于1000g的患者为4小时。两组婴儿在表面活性物质替代治疗后数分钟内氧合和气体交换均迅速改善。两组暴露于大于60%和大于40%氧气的情况相同。然而,出生体重低于1000g的婴儿暴露于大于21%氧气的时间明显更长(中位数30天,出生体重高于1000g的患者为8.5天,p<0.01)。出生体重高于1000g的患者机械通气时间为33天,低于1000g的为5天;p<0.01。所有婴儿均未发生气胸,但9名出生体重低于1000g的患者中有6名发生轻度支气管肺发育不良。2名出生体重低于1000g的婴儿分别在第5天和第11天因动脉导管未闭结扎后心循环骤停和医院获得性败血症死亡。出生体重低于1000g的患者机械通气时间延长和暴露于氧气不能仅归因于表面活性物质缺乏。(摘要截断于250字)

相似文献

1
[Surfactant substitution in severe respiratory distress syndrome in premature infants weighing less than 1,000 g].[体重低于1000克早产儿严重呼吸窘迫综合征中的表面活性剂替代治疗]
Geburtshilfe Frauenheilkd. 1990 May;50(5):359-64. doi: 10.1055/s-2008-1026261.
2
[Treatment of severe respiratory distress syndrome in the premature infant with natural surfactant].[天然表面活性剂治疗早产儿严重呼吸窘迫综合征]
Monatsschr Kinderheilkd. 1988 Feb;136(2):65-70.
3
Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.单剂量改良牛肺表面活性物质提取物(固尔苏)预防呼吸窘迫综合征的多中心试验。罗斯协作表面活性物质预防研究组
Pediatrics. 1990 Jun;85(6):1092-102.
4
Early versus late surfactant replacement therapy in severe respiratory distress syndrome.严重呼吸窘迫综合征的早期与晚期表面活性剂替代疗法
Lung. 1990;168 Suppl:870-6. doi: 10.1007/BF02718222.
5
A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.一项关于表面活性剂治疗呼吸窘迫综合征的多中心随机安慰剂对照试验。
N Engl J Med. 1989 Apr 13;320(15):959-65. doi: 10.1056/NEJM198904133201502.
6
[The effect of bovine surfactant in premature infants with respiratory distress syndrome. Results of an open, multicenter study].[牛肺表面活性物质对患有呼吸窘迫综合征早产儿的影响。一项开放性多中心研究的结果]
Z Geburtshilfe Perinatol. 1992 Jul-Aug;196(4):159-64.
7
Natural surfactant for neonatal respiratory distress syndrome in very premature infants: a 1992 update.用于极早产儿新生儿呼吸窘迫综合征的天然表面活性剂:1992年最新进展
J Perinat Med. 1992;20(6):409-19. doi: 10.1515/jpme.1992.20.6.409.
8
A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.一项针对体重1250克及以上患有呼吸窘迫综合征婴儿的合成表面活性剂对照试验。美国外源性表面活性物质新生儿研究组I和加拿大外源性表面活性物质新生儿研究组。
N Engl J Med. 1991 Dec 12;325(24):1696-703. doi: 10.1056/NEJM199112123252404.
9
Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf.欧洲关于严重新生儿呼吸窘迫综合征表面活性剂替代疗法的多中心随机试验:单剂量与多剂量珂立苏对比研究
Pediatrics. 1992 Jan;89(1):13-20.
10
Surfactant administration without intubation in preterm infants with respiratory distress syndrome--our experiences.未插管给予表面活性剂治疗呼吸窘迫综合征早产儿——我们的经验
J Matern Fetal Neonatal Med. 2015 Jul;28(10):1161-4. doi: 10.3109/14767058.2014.947571. Epub 2014 Aug 14.